NPPB and Stroke: According to an analysis from the Warfarin–Aspirin Recurrent Stroke Study (WARSS), a subpopulation of ischemic stroke patients with elevated NT-proBNP concentrations of more than 750 pg/mL may benefit more from anticoagulants than antiplatelet medications13.